European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
Maidenhead, England (ots/PRNewswire) - - Improvements in Purification Process Represent Important Advance in the Treatment of Haemophilia A Wyeth announced today it has received a positive decision from the European Commission for a variation of the marketing authorisation for ReFacto moroctocog alfa ...